~(99)Tc~m-MIBI肿瘤阳性显像的临床应用

The Clinical Application of Tumors Positive Imaging With ~(99)Tc~m-MIBI

  • 摘要: 探讨了 99Tcm- MIBI肿瘤阳性显像在多种恶性肿瘤临床诊断中的应用价值。静脉注射 99Tcm-MIBI15~ 30 min后, 用美国 GE公司 SPX- 6型 SPECT行病变局部平面和断层显像, 计算肿瘤与本底比值 (T/ B), 当 T/ B≥ 1.5时判定显像结果为阳性;肝脏肿瘤诊断则比较胶体显像和阳性显像时肿瘤部位是否有填充, 若有填充则为阳性。 2 1例受检者中病理诊断为恶性肿瘤 17例, 良性肿瘤 4例。 17例恶性肿瘤 99Tcm - MIBI阳性显像 15例阳性, 2例阴性;4例良性肿瘤患者显像结果均为阴性。本组病例 99Tcm- MIBI阳性显像的敏感性为 88%, 特异性为 10 0 %, 阳性预测值为 10 0 %, 阴性预测值为 6 6.7%, 准确率为 90 %。结果表明 99Tcm- MIBI阳性显像诊断和鉴别诊断良恶性肿瘤具有良好的临床应用前景

     

    Abstract: The clinical values of tumors positive imaging with 99 Tc m MIBI is evaluated. The imaging results of twenty one patients with tumors pathologically determined are studied in 15~30 min after injection of 99 Tc m MIBI using GE SPX 6 SPECT. The ratio of tumor to background(T/B) is calculated, and the positive results are determined when T/B≥1.5. The positive results also are obtained when space occupy lesion(SOL) of liver in colloid imaging are filled in 99 Tc m MIBI imaging. Seventeen of twenty one (17/21) patients have malignant tumors and four of twenty one (4/21) patients have benign tumors in pathologic diagnosis. In which fifteen of seventeen (15/17) patients with malignant tumors are positive, two of seventeen (2/17) patients with malignant tumors are negative, and four of four (4/4) patients with benign tumors are negative diagnosed by SPECT with 99 Tc m MIBI. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of tumor positive imaging with 99 Tc m MIBI are 88%, 100%, 100%, 66.7% and 90%, respectively. It shows that tumor positive imaging with 99 Tc m MIBI appears to be a useful method for diagnosis of malignant tumors.

     

/

返回文章
返回